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ABSTRACT
Introduction Trauma- focused cognitive behavioural 
therapies are the first- line treatment for posttraumatic 
stress disorder (PTSD) in children and adolescents. 
Nevertheless, open questions remain with respect to 
efficacy: why does this first- line treatment not work 
for everyone? For whom does it work best? Individual 
clinical trials often do not provide sufficient statistical 
power to examine and substantiate moderating factors. 
To overcome the issue of limited power, an individual 
participant data meta- analysis of randomised trials 
evaluating forms of trauma- focused cognitive behavioural 
therapy in children and adolescents aged 6–18 years will 
be conducted.
Methods and analysis We will update the National 
Institute for Health and Care Excellence guideline 
literature search from 2018 with an electronic search in 
the databases PsycINFO, MEDLINE, Embase, Cochrane 
Central Register of Controlled Trials and CINAHL with the 
terms (trauma* OR stress*) AND (cognitive therap* OR 
psychotherap*) AND (trial* OR review*). Electronic searches 
will be supplemented by a comprehensive grey literature 
search in archives and trial registries. Only randomised 
trials that used any manualised psychological treatment—
that is a trauma- focused cognitive behavioural therapy for 
children and adolescents—will be included. The primary 
outcome variable will be child- reported posttraumatic 
stress symptoms (PTSS) post- treatment. Proxy- reports 
(teacher, parent and caregiver) will be analysed separately. 
Secondary outcomes will include follow- up assessments 
of PTSS, PTSD diagnosis and symptoms of comorbid 
disorders such as depression, anxiety- related and 
externalising problems. Random- effects models applying 
restricted maximum likelihood estimation will be used for 
all analyses. We will use the Revised Cochrane Risk of Bias 
tool to measure risk of bias.
Ethics and dissemination Contributing study authors 
need to have permission to share anonymised data. 
Contributing studies will be required to remove patient 
identifiers before providing their data. Results will be 
published in a peer- reviewed journal and presented at 
international conferences.
PROSPERO registration number CRD42019151954.
INTRODUCTION
Within the last two decades, research in 
children and adolescents has tremendously 
increased our knowledge about trauma- 
related disorders such as posttraumatic stress 
disorder (PTSD), the long- lasting impact 
of potentially traumatic events (PTEs) and 
the efficacy of trauma- focused therapies 
in younger populations. Trauma- focused 
cognitive behavioural therapies are the first- 
line treatment for PTSD in children, adoles-
cents and adults.1 They are a category of 
Strengths and limitations of this study
 ► This is the first individual participant data meta- 
analysis (IPD- MA) of trauma- focused cognitive be-
havioural therapies in children and adolescents.
 ► In contrast to existing individual studies, an IPD- 
MA will provide the statistical power to examine 
moderating factors of trauma- focused cognitive 
behavioural therapies in children and adolescents.
 ► Only randomised controlled trials will be included to 
allow us to evaluate the efficacy of trauma- focused 
cognitive behavioural therapies over and above the 
non- specific effects of comparator conditions.
 ► A variety of measures of the primary and second-
ary outcomes will have been used in the individual 
studies bringing commensurate methodological and 
statistical complexity.
 ► Study findings will enhance the future provision 
and development of trauma- focused cognitive be-



















































































































2 de Haan A, et al. BMJ Open 2021;11:e047212. doi:10.1136/bmjopen-2020-047212
Open access 
psychological interventions including trauma- focused 
cognitive behavioural therapy,2 cognitive therapy for 
PTSD,3 prolonged exposure therapy for adolescents4 and 
the child- friendly version of narrative exposure therapy 
(KidNET5) (see the recent guideline from the National 
Institute for Health and Care Excellence (NICE)6).
Classic meta- analyses synthesising aggregated data 
from randomised controlled trials (RCTs) have shown 
that trauma- focused cognitive behavioural therapies are 
effective in reducing psychological distress including 
PTSD in children and adolescents.7–11 However, open 
questions remain with respect to clinical outcome: why 
does this first- line treatment not work for everyone? 
For whom does it work best? Factors that might impact 
the efficacy of trauma- focused cognitive behavioural 
therapies in children and adolescents form two broad 
categories: treatment- related and child- related factors. 
Treatment- related factors may include the length of 
therapy, involvement of parents in the intervention, and 
the balance of behavioural and cognitive intervention 
components. Child- related factors may include the type 
of trauma, the severity of symptoms, comorbid diagnoses, 
gender, age and other trauma- related or demographic 
variables. Current stand- alone RCTs invariably lack the 
power to explore the contribution of these factors to 
clinical outcomes, and have produced a mixed pattern of 
findings (eg, see references12–17). Further, classical meta- 
analysis, due to its reliance on summary data, is typically 
unable to comprehensively evaluate such moderating 
factors.
To overcome these problems of limited power we 
propose an individual participant data meta- analysis 
(IPD- MA) of randomised trials. By addressing the critical 
question about what works for whom, we hope to enhance 
the future provision and development of trauma- focused 
cognitive behavioural therapies in children and adoles-
cents. In a first step, our aim is to determine the efficacy 
of trauma- focused cognitive behavioural therapies for 
children and adolescents, relative to control and active 
comparison conditions. A second step then addresses our 
central aim to explore moderators of treatment effects, 
both treatment- related factors and child- related factors. 
Both of these aims are theory- driven and of high clinical 
relevance for successfully treating children and adoles-
cents who have been exposed to trauma. The following 
hypotheses will be examined:
 ► Hypothesis 1: trauma- focused cognitive behavioural 
therapies will produce a greater reduction in posttrau-
matic stress symptoms (PTSS) in children and adoles-
cents compared with either (1) no intervention (no 
treatment, waitlist), (2) treatment- as- usual (TAU), (3) 
individual non- trauma focused psychosocial interven-
tions or (4) other individual trauma- focused psycho-
social interventions.
 ► Hypothesis 2a: efficacy of trauma- focused cognitive 
behavioural therapies will be significantly predicted by 
predefined treatment- related factors available at trial 
baseline. Due to the mixed findings from previous 
studies, non- directional hypotheses will be tested. 
Post- treatment PTSS will be significantly predicted by:
 – Predefined intended length of treatment (number 
of sessions).
 – Predefined intended involvement of caregivers.
 ► Hypothesis 2b: child- related factors will serve as prog-
nostic predictors for the efficacy of trauma- focused 
cognitive behavioural therapies. Due to the mixed 
findings from previous studies, non- directional 
hypotheses will be tested. Post- treatment PTSS will be 
significantly predicted by:
 – Age of the participants at the start of treatment.
 – Gender.
 – Trauma- type of index- event.
 – Trauma- history.
 – Severity of PTSS pretreatment.
METHODS AND ANALYSIS
Study registration and management
This IPD- MA will be conducted in accordance with 
Preferred Reporting Items for a Systematic Review and 
Meta- Analysis of Individual Participant Data (the PRIS-
MA- IPD statement18). Regular email updates will be sent 
to inform the collaborating network of study progress. 
End- to- end encrypted electronic data- sharing clouds and 
email will be used to exchange pseudo- anonymised data 
and paperwork between researchers.
Patient and public involvement
Patients were not involved in this study. However, 
secondary data analysis ensures maximum return from 
patient involvement in research. The outcome of this 
IPD- MA will be published in an international peer- 
reviewed journal. The findings will further be presented 
at international conferences.
Ethics and dissemination
We will cite the ethics code for each contributing study in 
the published paper. Contributing studies will be required 
to remove patient identifiers before providing their data. 
This includes names, addresses, and date of birth which 
will be converted to age- at- index- trauma- event and age- at- 
time- of- assessment. Contributing studies will need to have 
permission to share anonymised data.
Criteria for included studies
Types of studies
Only randomised studies will be included in this IPD- MA. 
Articles must be written in English. Unpublished data 
will be actively sought; hence, non- peer- reviewed studies 
will also be included. We will perform sensitivity analyses 
to evaluate the impact of published versus unpublished 
studies on our results.
Participants
Studies must have recruited children and adolescents aged 
6–18 years exposed to a single- event trauma (eg, road traffic 
accident) or multi- event trauma (eg, domestic violence) 
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qualifying traumatic event. We will request studies with a 
broader age range; however, only participants within our 
defined age range will be included in the IPD- MA. Sensi-
tivity analyses will be conducted if the adult version of a 
treatment were administered to an adolescent sample. 
A standardised outcome measure comprising either a 
diagnostic interview indexing symptom severity or a self- 
report measure of PTSS must have been administered 
before and after treatment. Furthermore, a clinically rele-
vant degree of severity of PTSS at trial baseline must have 
been present as assessed either by scoring above a vali-
dated cut- off on a PTSS rating scale or by meeting criteria 
for PTSD. We will also request studies that include both 
children and adolescents with and without clinically rele-
vant severity of PTSS as defined earlier. However, again, 
only those participants with clinically relevant severity of 
PTSS will be included in the analyses.
Treatments
In line with the NICE guideline,6 we will include studies 
that used any manualised psychological treatment that 
we deem to be a trauma- focused cognitive behavioural 
therapy for children and adolescents. This includes 
cognitive therapy, cognitive processing therapy, compas-
sion focused therapy, exposure therapy/prolonged expo-
sure, virtual reality exposure therapy, imagery rehearsal 
therapy and KidNET. We furthermore adopt NICE guide-
line description of trauma- focused cognitive behavioural 
therapy as laid out in the associated paper (Mavranezouli 
et al,
10 p19); namely, ‘a broad class of psychological inter-
ventions that predominantly use trauma- focused cogni-
tive, behavioural or cognitive behavioural techniques 
and exposure approaches to treatment. Although some 
interventions place their main emphasis on exposure 
(eg, imaginal reliving, producing a written narrative or 
in vivo exposure) and others on cognitive techniques 
(eg, restructuring of trauma- related appraisals), most 
use a combination’. Independent raters will evaluate 
author descriptions of their treatment with respect to 
this definition to determine inclusion within the IPD- MA. 
In contrast to the NICE guideline,6 we will not include 
mindfulness- based cognitive therapy as a trauma- focused 
cognitive behavioural therapy.
In addition, treatment may be delivered in- person or 
online, but must comprise an individual-, rather than 
group- format, and a multi- session treatment protocol. A 
minimum of at least one post- treatment/ follow- up assess-
ment must have been reported.
Comparison conditions
Trauma- focused cognitive behavioural therapies will be 
compared: (1) against no intervention (no treatment, 
waitlist); (2) against TAU; (3) against individual non- 
trauma focused psychosocial interventions or (4) against 
other individual trauma- focused psychosocial interven-
tions. Again, comparison condition type will be deter-
mined by two independent raters, based on the author 
descriptions.
Primary outcomes
The primary outcome variable will be child- reported 
PTSS using a standardised self- report post- treatment (see 
the Strategy for data synthesis section for further infor-
mation). Proxy- reports (teacher, parent and caregiver) 
will be analysed separately. The primary endpoint of post- 
treatment will be indexed as the assessment completed 
immediately after completion of trauma- focused cogni-
tive behavioural therapy, less than 1 month after the final 
treatment session.
Secondary outcomes
Secondary outcomes will include: (1) follow- up assess-
ments of PTSS; (2) PTSD diagnoses and (3) symptoms 
of comorbid disorders such as depression, anxiety- related 
and externalising problems, reported via self- reports and 
proxy- reports. Follow- up lengths to be included comprise 
assessments between 1 month and 2 years following the 
completion of therapy. During analysis, studies including 
a follow- up assessment between 1 and 3 months post- 
treatment will be grouped to form a short- term follow- up, 
and any later assessment points will be grouped per 
6- month period (ie, 6 months, 12 months). This will result 
in analysis of follow- up outcomes in the short- term (1–3 
months), and at 6, 12, 18 and 24 months post- treatment.
Search methods for identification of studies and obtaining 
datasets
Figure 1 depicts our multi- layered search method in order 
to obtain all potential studies, published and unpublished 
(in line with the PRISMA- IPD statement18).
Electronic searches
Publications identified by the latest NICE guideline for 
PTSD published in 2018 will be included (NICE guideline 
search was completed on 29 January 2018). To update the 
results of the NICE search, an electronic search using the 
same databases will be restricted to publications between 
the 1 January 2018 and 12 November 2019. We will repli-
cate the NICE guideline search by using the same search 
terms related to trauma- focused cognitive behavioural 
therapies. We will exclude specific search terms that are 
not related to a psychosocial intervention and thereby 
unlikely to include a cognitive- behavioural therapy 
approach. This includes physiotherapy and biological 
interventions (eg, transcranial magnetic stimulation). 
We will also exclude specific terms defining any inter-
vention that is not cognitive behaviour therapy- based, 
for example, hypnosis or dance therapy. Finally, we will 
remove terms referring to occupational/return to work 
support.
Searches in the databases PsycINFO via EBSCOhost, 
MEDLINE via Ovid, Embase via Ovid, Cochrane Central 
Register of Controlled Trials (CENTRAL) via Cochrane 
Library, CINAHL via EBSCOhost will use the following 
search plan: (trauma* OR stress*) AND (cognitive 
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(see online supplemental material 1 for the full search 
strategy).
No language restrictions will be applied to the search, 
but only studies published in English will be included. 
Search results will be deduplicated in Endnote (by 
IK), then imported into Rayyan (a web- based tool for 
managing systematic reviews19). This will allow for blind 
screening by raters. Two raters will independently review 
title and abstract of the records identified in the electronic 
search. The raters will review the records according to the 
following exclusion criteria applying the same exclusion 
order: (1) duplicate; (2) language other than English; 
(3) review or meta- analysis; (4) no randomised trial; (5) 
no applicable age range extractable; (6) no manualised 
trauma- focused cognitive behavioural therapy; (7) group- 
format; (8) single- session treatment; (9) no assessment 
post- treatment; (10) no standardised outcome measure 
to assess PTSS; (11) no clinically relevant PTSS extract-
able; (12) comparison condition outside protocol. 
Records deemed ineligible from title and abstract by 
both raters will be set aside. Records appearing eligible 
(ie, not meeting any exclusion criterion) or where eligi-
bility can not be determined due to insufficient infor-
mation in the abstract will proceed to the full- text stage. 
Again, at the full- text stage, two raters will examine the 
remaining records independently. Any disagreements will 
be resolved via discussion with RM- S, MAL and TD.
Grey literature
Clinical trial registries and archives will be searched up 
to the 12 November 2019 using the following search 
string: (child* OR adolesc* OR youth OR young*) AND 
(PTSD OR posttraumatic stress disorder). We will use the 
trial registries  ClinicalTrials. gov and ISRCTN to identify 
any relevant unpublished trials, including those that are 
currently ongoing. Moreover, the archives PsyArXiv and 
bioRxiv will be searched to identify any relevant preprints 
up to 6 months prior (12 May 2019) of the electronic 
search (12 November 2019). Finally, we will check refer-
ence lists of included studies and relevant meta- analyses 
identified by the electronic search to make sure that all 
available trials will have been detected by the NICE guide-
line, our electronic search, and grey literature search.
Non-literature based searching
Key authors will be contacted via email to request any 
unpublished datasets, and Twitter will be used to raise 
awareness of the IPD- MA.
Data collection
Corresponding authors of eligible studies will be emailed 
to request data. A reminder email will be sent after two 
weeks. If an author does not respond after two emails, 
another author of the study will be contacted as well 
(either first, second or last author). A second attempt to 
contact both authors together will follow. A maximum 
of three authors per article will be contacted. We will 
consider study data unavailable if no study authors 
respond to multiple contact attempts, or if authors indi-
cate that they no longer have access to the data or do not 
wish to make their data available. A single person for each 
included study will be designated to whom all queries 
about the data collection processes and transformation 
of individual variables will be addressed. When cleaning 
and preparing a specific data set, communication with 
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the original investigators will take place by email or 
telephone.
Data extraction, quality checks and storage
The primary variables to be requested from study investi-
gators are listed in table 1. We aim to collect data on all 
of these variables from all studies, regardless of whether 
such data were previously published. For all outcomes, 
unimputed and untransformed data will be requested. 
Data will be cleaned and stored separately for each study. 
Spot checks will be completed to ensure data quality. The 
pattern of treatment allocation for each included study 
will be checked to ensure that randomisation and allo-
cation sequence appear appropriate, in accordance with 
guidelines recommended by Tierney et al.20 For final 
checks before analysis and the statistical analyses, the 
datasets will be combined into a single dataset. Data will 
be stored in password- protected files on an encrypted 
University of Cambridge server.
Risk of bias
Two raters will independently evaluate the risk of bias for 
the included studies by using the revised Cochrane Risk 
of Bias tool (RoB 221) to access study quality and risk of 
bias due to the randomisation process, deviations from 
intended interventions, missing outcome data, measure-
ment of the outcome and selection of the reported result. 
Each study will be rated as of high risk, some concerns, 
or low risk.
Table 1 Individual participant data to be extracted from included studies
Treatment- related factors Child- related factors Outcomes
Descriptives Demographics   
Trial identifier Anonymised participant identifier   
Country of completion Gender   
Information about risk of bias Age   
Type of trauma- focused cognitive 
behavioural therapy
Ethnicity   
Type of comparison group/s Trauma type of index- event   
Number of sessions Trauma history   
Length of treatment in weeks     
Involvement of caregivers     
Any potential covariates (eg, mode of 
administration, profession of therapists)
Any potential covariates (eg, pretreatment 
levels of dysfunctional posttraumatic 
cognitions, IQ, social support, treatment 
expectancy, therapeutic alliance)
Any related outcome variables (eg, 
post- treatment level of dysfunctional 
posttraumatic cognitions and 
changes in coping behaviours)
  Psychological symptoms pre- treatment Psychological symptoms post- 
treatment and follow- up
  Pre- treatment self- reported and proxy- 
reported PTSS
Self- reported and proxy- reported 
PTSS post- treatment and follow- up
  Pre- treatment self- reported and proxy- 
reported depression symptoms
Self- reported and proxy- reported 
depression symptoms post- treatment 
and follow- up
  Pre- treatment self- reported and proxy- 
reported anxiety- related symptoms
Self- reported and proxy- reported 
anxiety- related symptoms post- 
treatment and follow- up
  Pre- treatment self- reported and proxy- 
reported externalising problems
Self- reported and proxy- reported 
externalising problems post- 
treatment and follow- up
  Diagnoses pre- treatment Diagnoses post- treatment and follow- 
up
  Pre- treatment diagnostic status of PTSD Diagnostic status of PTSD post- 
treatment and follow- up
  Pre- treatment diagnostic status of comorbid 
disorders
Diagnostic status of comorbid 
disorders post- treatment and follow- 
up
  Reason for missing data Reason for missing data Reason for missing data
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Strategy for data synthesis
Data will be analysed across a series of stages, in order to 
be guided by data availability and the degree of potential 
for harmonisation. Unimputed and untransformed data 
will be requested.
First, for published studies, key variables will be re- anal-
ysed within each study (eg, participant numbers per treat-
ment condition, mean PTSS scores pretreatment and 
post- treatment, numbers gender, mean age), as to iden-
tify any potential inconsistencies in the supplied data.
Second, data will be harmonised as far as possible: (1) 
the definitions and scales of outcomes (eg, standard-
ising PTSS total scores across different measures); (2) 
the timings of measurements (eg, pretreatment defined 
as the assessment directly before start of treatment; 
post- treatment defined as the assessment immediately 
after completing treatment, less than 1 month after the 
final treatment session); (3) the definitions, scales and/
or subgroups used for covariates (eg, the specific index 
trauma event will be grouped into accidental trauma, 
natural disaster, war trauma, or interpersonal trauma).
Third, depending on the amount of missing data and 
whether missing at random assumptions are met, multiple 
imputation will be carried out.
Based on the stepwise approach described earlier, 
decisions may be made for example, to put aside certain 
desired analyses or adjustment factors if it is felt that data 
are too limited and may bias results. Once the final consti-
tution of the model has been agreed based on the above, 
we will proceed to the meta- analysis pooling itself. Note 
that modelling will be done for each outcome (as specified 
in table 1) separately. All analyses will be completed using 
random- effects models employing restricted maximum 
likelihood estimation. However, if there is considerable 
heterogeneity in the quality of studies (indexed by RoB 
2), a sensitivity analysis will be completed comparing 
random- effects and fixed- effects models.
Depending on the IPD data sets we receive, we will 
collect aggregate data (AD) from studies where IPD 
could not be obtained and combine it with the IPD to 
tackle inclusion bias.22 In this case, sensitivity analyses will 
be performed comparing an IPD- only meta- analysis with 
a meta- analysis that combines IPD and AD.
One- stage approaches will be applied using the R 
software.23 We will investigate the overall summary of 
treatment effect and we are further interested in the 
heterogeneity in treatment effect across- studies and 
within- studies. If the one- stage model fails to converge, a 
two- stage model will be calculated.
Hypothesis 1
A one- stage linear mixed effects (LME) model with random 
intercept and outcome baseline adjustment with different 
residual variance per study will be applied to analyse the effect 
of trauma- focused cognitive behavioural therapies on the 
continuous outcome of PTSS post- treatment. A mixed effects 
logistic regression model will be used to analyse the treatment 
effect on the binary outcome PTSD diagnosis post- treatment. 
Sensitivity analysis will be completed contrasting a (single) 
random intercept (as primary) with a separate fixed inter-
cept for each study (as sensitivity). As described earlier, if the 
one- stage model fails to converge, a two- stage model will be 
completed.
Hypothesis 2a
We will use meta- regression to explore whether the overall 
effect of trauma- focused cognitive behavioural therapies 
varies in relation to treatment- related factors such as 
predefined intended length of treatment and predefined 
intended involvement of caregivers.
Hypothesis 2b
To investigate whether the overall effect of trauma- focused 
cognitive behavioural therapies varies by child- related 
factors such as age, gender, trauma type of index- event, 
trauma- history and symptom severity pretreatment, 
subject- level interactions will be investigated. Interaction 
term between treatment status and subject- level covari-
ates will be specified.22
Random- effects distributions for the interaction effects 
will be specified. Effects on the continuous primary 
outcome of PTSS post- treatment will be analysed using a 
one- stage LME model with random intercept to account 
for correlation between the interaction estimate and 
other parameter estimates. Patient- level covariates will 
be centred to separate within- trial and across- trial effects. 
A mixed effects logistic regression model for the binary 
secondary outcome of PTSD diagnosis post- treatment 
will be applied. Sensitivity analysis will be completed 
contrasting a (single) random intercept (as primary) with 
a separate fixed intercept for each study (as sensitivity). As 
described earlier, if the one- stage model fails to converge, 
a two- stage model will be completed.
Additional analyses with subsamples
Depending on the data provided, we will investigate 
further treatment- related factors such as predefined 
mode of administration, profession of therapists and 
treatment expectancy pretreatment. Moreover, addi-
tional child- related factors such as comorbidity pretreat-
ment, pretreatment levels of dysfunctional posttraumatic 
cognitions, IQ and pretreatment parental mental health 
will be addressed.
Future analyses
In future investigations of the obtained data, we plan to 
conduct mediation analyses within the IPD- MA context to 
evaluate mechanisms of action of trauma- focused cogni-
tive behavioural therapies. The most promising candidates 
seem to be changes in targeted cognitive and behavioural 
processes; for example, improvements in dysfunctional 
posttraumatic cognitions of the child regarding being 
permanently and disturbingly changed, or feeling vulner-
able,24–26 as well as changes in safety- seeking behaviours.25
Moreover, we are aiming to investigate non- responding, 
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from trauma- focused cognitive behavioural therapies 
across studies.
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